SEI Investments
XGN icon

SEI Investments’s Exagen XGN Stock Holding History

SEI Investments’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$733K Buy
244,240
+126,235
+107% +$488K ﹤0.01% 2505
2025
Q4 		$717K Buy
+118,005
New +$1.07M ﹤0.01% 2332

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

SEI Investments's XGN Position: Q1 2026 in Review

SEI Investments increased its Exagen (XGN) stake by 107% in Q1 2026, buying an estimated $488K and bringing the position to 244,240 shares worth $733K. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

SEI Investments first reported a position in XGN in Q4 2025 and has held it in 2 quarters since. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • SEI Investments held 244,240 shares of Exagen worth $733K as of Q1 2026.
  • SEI Investments bought 126,235 Exagen shares in Q1 2026, an estimated $488K.
  • Exagen made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2505 holding.
  • SEI Investments first reported a position in Exagen in Q4 2025 and has held it in 2 quarters since.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.